home > ebr > > pharma research meets synthetic biology


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


Industry Events

4th Annual Drug Delivery and Formulation Asia Summit

12-14 November 2014, Wyndham Bund East Shanghai Hotel, Shanghai, China

Since 2011 when DDF Asia Summit was launched, with you kindly supports we have went through 3 years. We bring it up as a child with the expectation that more and more people will like it. DDF Asia summit is devoted to adding value to our clients and promoting industry progress.
More info >>

News and Press Releases

INC Research Files Registration Statement for Initial Public Offering

Raleigh, N.C., Oct. 6, 2014 – INC Research Holdings, Inc. (INC Research), a leading, global Phase I to IV contract research organization, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock. The number of shares to be offered by INC Research and its stockholders and the price range for the offering have not yet been determined. The Company has applied to list its common stock on The NASDAQ Global Market under the ticker symbol “INCR.” INC Research expects to use the net proceeds it receives from the offering to refinance its existing long-term debt as further specified in the registration statement.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement